title: [Use of liquid-based endometrial cytology in breast cancer patients receiving tamoxifen].
abstract: Fifty-four (54) breast cancer patients, receiving tamoxifen, were enrolled into an evaluation of the status of the endometrium. Liquid-based cytology and immuno-cytochemical analysis were used for assessment. Our method proved viable in selective screening for differential diagnosis of endometrial pathology and cancer detection.
authors.forename: A É
authors.initials: AÉ
authors.lastname: Protasova
authors.forename: G A
authors.initials: GA
authors.lastname: Raskin
authors.forename: R V
authors.initials: RV
authors.lastname: Orlova
authors.forename: D A
authors.initials: DA
authors.lastname: Protasov
authors.forename: N V
authors.initials: NV
authors.lastname: Tiukavina
mesh_terms: D000328:Adult; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003581:Cytodiagnosis / Q000379:methods; D003937:Diagnosis, Differential; D004717:Endometrium / Q000187:drug effects* / Q000473:pathology; D005260:Female; D016591:Histocytological Preparation Techniques / Q000379:methods*; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis; D008875:Middle Aged; D051059:PTEN Phosphohydrolase / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects*; D014594:Uterine Neoplasms / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology
chemical_list: D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human